Brandinium

Trademark search for:

PERFORM PATIENT REGISTRY

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2022-11-03 — Application filed
  • 2023-01-26 — Sn assigned for sect 66a appl from ib
  • 2023-01-27 — Application filed
  • 2023-01-31 — Application filed
  • 2023-07-24 — New representative at ib received
  • 2023-08-18 — Final disposition recorded
  • 2023-08-18 — Assigned to examiner
  • 2023-08-19 — Office action issued
  • 2023-09-11 — Office action issued
  • 2023-09-11 — Office action issued
  • 2023-10-04 — Office action issued
  • 2024-01-02 — Approved for pub - principal register
  • 2024-01-02 — Teas/email correspondence entered
  • 2024-01-02 — Office action issued
  • 2024-01-02 — Correspondence received in law office
  • 2024-01-16 — Withdrawn from pub - og review query
  • 2024-02-14 — Official gazette publication confirmation e-mailed
  • 2024-02-14 — Notification of possible opposition sent to ib
  • 2024-02-14 — Notification of notice of publication e-mailed
  • 2024-02-14 — Notice of start of opposition period created, to be sent to ib
  • 2024-03-04 — Notification processed by ib
  • 2024-03-05 — Published for opposition
  • 2024-03-05 — Official gazette publication confirmation e-mailed
  • 2024-05-21 — Registered-principal register
  • 2024-05-21 — Notice of registration confirmation emailed
  • 2024-06-01 — Death of international registration
  • 2024-06-01 — Notification of effect of cancellation of intl reg e-mailed
  • 2024-06-04 — Teas request for transformation received
  • 2024-08-22 — Final status recorded

Owner Information

Calliditas Therapeutics AB
SE
Calliditas Therapeutics AB
SE
Calliditas Therapeutics AB
SE

Correspondent

Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
151 W 42nd St 17th floor
New York, NY 10036
United States

Filing Details

Filing Date:
2022-11-03
Status Date:
2024-08-22
Category:
Science & Technology Services
Filing Year:
2022

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.